LAMB2 and muscular dystrophy-dystroglycanopathy, type A: Dystroglycanopathies are a group of diseases characterized by impaired laminin-DAG1 interaction, including Walker-Warburg syndrome [48], muscle-eye-brain disease [49], and Fukuyama congenital muscular dystrophy [50].